Intermittent, low-dose, antiandrogen monotherapy as an alternative therapeutic option for patients with positive surgical margins after radical prostatectomy

The aim of the present study was to determine whether oncologic outcomes and adverse events associated with active on/off intermittent antiandrogen monotherapy (daily bicalutamide, 50 mg per day) are comparable with those of standard external beam radiation therapy (EBRT) or combined androgen blocka...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Kyung Hwa, Lee, Seung Ryeol, Hong, Young Kwon, Park, Dong Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952482/
https://www.ncbi.nlm.nih.gov/pubmed/29271399
http://dx.doi.org/10.4103/aja.aja_56_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952482/
https://www.ncbi.nlm.nih.gov/pubmed/29271399
http://dx.doi.org/10.4103/aja.aja_56_17

Ejemplares similares